Gilead Sciences, Inc.Foster City, California, United States
Disclosure(s): Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)
507 - Trajectories of Newly Initiated Pre-Exposure Prophylaxis (PrEP) Use among Priority Populations with Unmet Needs for PrEP in the USA
Saturday, October 19, 202411:15 AM – 11:30 AM US PT
